The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
 
Steven C. Kuijper
No Relationships to Disclose
 
Marieke Pape
Research Funding - Bristol-Myers Squibb (Inst)
 
Nadia Haj Mohammad
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb/Pfizer (Inst); Merck/Pfizer (Inst); Servier (Inst)
 
Thymen Van Voorthuizen
No Relationships to Disclose
 
Aeilko H. Zwinderman
Consulting or Advisory Role - Torrent Pharmaceuticals
 
Rob Verhoeven
Research Funding - Bristol-Myers Squibb (Inst)
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Bristol-Myers Squibb; Dragonfly Therapeutics; Merck; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca